Bengt Nilsson - Concepedia

Author

Bengt Nilsson

Also Known As

B Y Nilsson, B. -Y. Nilsson, B. Y. NILSSON, B. Y. Nilsson, B.Y. Nilsson, BENGT NILSSON, BENGT Y. NILSSON, BENGT YNGVE NILSSON, Bengt Nilsson, Bengt Y Nilsson

119

Publications

8.7K

Citations

H-Index

193

Concepts

All Affiliations

Karolinska Institutet Stockholm South General Hospital Lund University Sahlgrenska University Hospital University of Gothenburg

About

Bengt Nilsson is an author at Karolinska Institutet specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	54	2.8K
2	Health Sciences	15	18	956
3	Social Sciences	10	10	371
4	Engineering	2	2	86
5	Public Health	2	2	66

Bengt Nilsson

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era Bengt Nilsson, Per Bümming, Jeanne M. Meis‐Kindblom, Cancer	2005	1.3K
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, JAMA	2012	955
CEREBRAL BLOOD FLOW AND METABOLIC RATE EARLY AND LATE IN PROLONGED EPILEPTIC SEIZURES INDUCED IN RATS BY BICUCULLINE Brian S. Meldrum, Bengt Nilsson Brain	1976	296
Gastrointestinal Stromal Tumors With KIT Exon 11 Deletions Are Associated With Poor Prognosis Johanna C. Andersson‐Assarsson, Per Bümming, Jeanne M. Meis‐Kindblom, Gastroenterology Tumor BiologyGastrointestinal OncologyMedicineSurgical PathologyGastroenterology	2006	239
Improved Survival of Patients with Papillary Thyroid Cancer after Surgical Microdissection Lars‐Erik Tisell, Bengt Nilsson, Johan Mölne, World Journal of Surgery	1996	230
Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Journal of Clinical Oncology	2015	225
Intensified conventional insulin treatment retards the microvascular complications of insulin‐dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years Per Reichard, Bo Berglund, Alice Einsfeld Britz, Journal of Internal Medicine Metabolic SyndromeDiabetic RetinopathySerious HypoglycaemiaInsulin DeliveryChronic Kidney Disease	1991	223
Effect of <i>KIT</i> and <i>PDGFRA</i> Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib Heikki Joensuu, Eva Wardelmann, Harri Sihto, JAMA Oncology	2017	185
<i>KIT</i> and <i>PDGFRA</i> Mutations and the Risk of GI Stromal Tumor Recurrence Heikki Joensuu, Piotr Rutkowski, Toshirou Nishida, Journal of Clinical Oncology	2015	172
Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, JAMA Oncology	2020	170

Page 1